Presentation Open Access
HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level
Harding, Rachel
Presentation at HDSA Convention 2019 in Boston in "Moving Beyond Mice: Understanding HD in People" session.
Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
(29.3 MB)
| Name | Size | |
|---|---|---|
|
HDSA_convention_RHarding_2019.pdf
md5:77c80a88d099f346fb53c9c437b1e730 |
29.3 MB | Download |
64
95
views
downloads
| All versions | This version | |
|---|---|---|
| Views | 64 | 64 |
| Downloads | 95 | 95 |
| Data volume | 2.8 GB | 2.8 GB |
| Unique views | 57 | 57 |
| Unique downloads | 91 | 91 |
Indexed in
- Publication date:
- June 28, 2019
- DOI:
-
- Keyword(s):
- Huntingtin Huntington's disease HDSA
- Communities:
- License (for files):
- Creative Commons Attribution 4.0 International